Financhill
Back

Perspective Therapeutics Vs. Plus Therapeutics Industry Stock Comparison

Sell
23

CATX
Perspective Therapeutics

Last Price:
$2.87
Seasonality Move:
41.25%
Sell
24

PSTV
Plus Therapeutics

Last Price:
$1.09
Seasonality Move:
5.93%
Sell
23
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $2.85. The Score for CATX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
24
Plus Therapeutics (PSTV) is a Sell

Is Plus Therapeutics a Buy, Sell or Hold?

  • The current Plus Therapeutics [PSTV] share price is $1.09. The Score for PSTV is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • PSTV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $2.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

PSTV Stock Price Chart

What is Plus Therapeutics's stock price today?

  • The Plus Therapeutics share price today is $1.09
    The current trend is relatively stagnant and PSTV is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.39 Sell
Relative Strength Index (14 RSI): 19.38 Sell
Chaikin Money Flow: -1073375 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.81 - 5.45) Sell
Bollinger Bands (100): (6.72 - 15.04) Sell

PSTV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 39.12 Sell
Chaikin Money Flow: 34849 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.12 - 1.34) Sell
Bollinger Bands (100): (1.23 - 1.53) Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.2 Sell
20-day SMA: 3.62 Sell
50-day SMA: 7.99 Sell
200-day SMA: 12.2 Sell
8-day EMA: 3.18 Sell
20-day EMA: 4.2 Sell
50-day EMA: 6.97 Sell
200-day EMA: 10.01 Sell

PSTV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.16 Sell
20-day SMA: 1.24 Sell
50-day SMA: 1.29 Sell
200-day SMA: 1.63 Sell
8-day EMA: 1.13 Sell
20-day EMA: 1.21 Sell
50-day EMA: 1.29 Sell
200-day EMA: 1.64 Sell

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

Plus Therapeutics Earnings Growth & PSTV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.80 per share, and a decrease next year of $0.04 per share.

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Plus Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):